Neutrophil/Lymphocyte Ratio Helps Select Metastatic Pancreatic Cancer Patients Benefitting From Oxaliplatin
Cancer Biomarkers - Netherlands
doi 10.3233/cbm-160645
Full Text
Open PDFAbstract
Available in full text
Date
September 26, 2016
Authors
Publisher
IOS Press